<DOC>
	<DOCNO>NCT00520260</DOCNO>
	<brief_summary>To compare bromfenac 0.09 % ketorolac 0.4 % use concomitantly cyclosporine ophthalmic emulsion 0.05 % improve patient comfort induction phase treatment chronic dry eye disease</brief_summary>
	<brief_title>Bromfenac 0.09 % v Ketorolac 0.4 % Cyclosporine Induction Phase</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Must general good health Diagnosis moderate severe dry eye syndrome Patients unlikely respond cyclosporine ophthalmic emulsion therapy Patients pregnant nursing female Unwilling discontinue use contact lenses runin duration study Presence history systemic ocular disorder condition could possibly interfere interpretation study result study eye Previous treatment failure CSA 0.05 % ( Restasis ) Known hypersensitivity component study procedural medication Participation clinical trial within 30 day prior screen Known contraindication study medication component . Should take oral antihistamine , beta blocker diuretic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>